Canada · Delayed Price · Currency is CAD CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of CAD 157.19 billion. The enterprise value is 246.13 billion.
| Market Cap | 157.19B |
| Enterprise Value | 246.13B |
Important Dates
The next confirmed earnings date is Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Oct 22, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 90.18% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 22.64 and the forward PE ratio is 10.54.
| PE Ratio | 22.64 |
| Forward PE | 10.54 |
| PS Ratio | 0.27 |
| PB Ratio | 1.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.41 |
| P/OCF Ratio | 7.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.79, with an EV/FCF ratio of 14.74.
| EV / Earnings | 35.44 |
| EV / Sales | 0.42 |
| EV / EBITDA | 8.79 |
| EV / EBIT | 14.24 |
| EV / FCF | 14.74 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.96.
| Current Ratio | 0.87 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 3.87 |
| Debt / FCF | 6.49 |
| Interest Coverage | 3.92 |
Financial Efficiency
Return on equity (ROE) is 6.21% and return on invested capital (ROIC) is 7.17%.
| Return on Equity (ROE) | 6.21% |
| Return on Assets (ROA) | 2.97% |
| Return on Invested Capital (ROIC) | 7.17% |
| Return on Capital Employed (ROCE) | 7.29% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.26M |
| Profits Per Employee | 26,760 |
| Employee Count | 300,000 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 20.32 |
Taxes
In the past 12 months, CVS Health has paid 1.28 billion in taxes.
| Income Tax | 1.28B |
| Effective Tax Rate | 15.59% |
Stock Price Statistics
The stock price has increased by +8.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +8.67% |
| 50-Day Moving Average | 22.51 |
| 200-Day Moving Average | 21.10 |
| Relative Strength Index (RSI) | 36.34 |
| Average Volume (20 Days) | 10,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.07 |
Income Statement
In the last 12 months, CVS Health had revenue of CAD 586.00 billion and earned 6.94 billion in profits. Earnings per share was 5.42.
| Revenue | 586.00B |
| Gross Profit | 79.96B |
| Operating Income | 17.27B |
| Pretax Income | 8.22B |
| Net Income | 6.94B |
| EBITDA | 23.69B |
| EBIT | 17.27B |
| Earnings Per Share (EPS) | 5.42 |
Balance Sheet
The company has 19.82 billion in cash and 108.36 billion in debt, with a net cash position of -88.54 billion.
| Cash & Cash Equivalents | 19.82B |
| Total Debt | 108.36B |
| Net Cash | -88.54B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 113.46B |
| Book Value Per Share | 88.56 |
| Working Capital | -16.61B |
Cash Flow
In the last 12 months, operating cash flow was 20.99 billion and capital expenditures -4.29 billion, giving a free cash flow of 16.70 billion.
| Operating Cash Flow | 20.99B |
| Capital Expenditures | -4.29B |
| Depreciation & Amortization | 6.43B |
| Net Borrowing | -7.43B |
| Free Cash Flow | 16.70B |
| FCF Per Share | n/a |
Margins
Gross margin is 13.64%, with operating and profit margins of 2.95% and 1.19%.
| Gross Margin | 13.64% |
| Operating Margin | 2.95% |
| Pretax Margin | 1.40% |
| Profit Margin | 1.19% |
| EBITDA Margin | 4.04% |
| EBIT Margin | 2.95% |
| FCF Margin | 2.85% |
Dividends & Yields
This stock pays an annual dividend of 0.63, which amounts to a dividend yield of 3.07%.
| Dividend Per Share | 0.63 |
| Dividend Yield | 3.07% |
| Dividend Growth (YoY) | -3.42% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 69.86% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.19% |
| Shareholder Yield | 1.89% |
| Earnings Yield | 4.42% |
| FCF Yield | 10.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.43 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 7 |